Clinical Trial: NCT04160910
5HTP Regulation Of Asthma In Children
Status:
RECRUITINGPhase:
Phase 2| Lead Sponsor: | Indiana University |
| Information Provided By: | Indiana University |
| Last Update Posted: | 2026-10-01 |
Study Overview
Brief Summary
The purpose of this study is to learn more about if taking a supplement called 5-hydroxytryptophan (5HTP) can improve breathing and anxiety symptoms related to asthma. To help learn more subjects will either be assigned to a group that is taking the supplement (5HTP) or a group that is taking a placebo. This will be decided randomly. Later in the study subjects will crossover to the other group.There are 5 study visits over the course of about 12 weeks.
Official Title
Conditions
Intervention / Treatment
- Drug: 5-Hydroxytryptophan
- Drug: Placebo
Other Study ID Numbers
- Kloepfer_1902366300
Start Date (Actual)
Primary Completion Date (Estimated)
Study Completion Date (Estimated)
Enrollment (Estimated)
Study Type
Phase
| Lead Sponsor: | Indiana University |
| Information Provided By: | Indiana University |
| Last Update Posted: | 2026-10-01 |
Study Overview
Brief Summary
The purpose of this study is to learn more about if taking a supplement called 5-hydroxytryptophan (5HTP) can improve breathing and anxiety symptoms related to asthma. To help learn more subjects will either be assigned to a group that is taking the supplement (5HTP) or a group that is taking a placebo. This will be decided randomly. Later in the study subjects will crossover to the other group.There are 5 study visits over the course of about 12 weeks.
Official Title
Conditions
Intervention / Treatment
- Drug: 5-Hydroxytryptophan
- Drug: Placebo
Other Study ID Numbers
- Kloepfer_1902366300